NCT04081285Completed
Epigenetic Biomarkers for Alzheimer's Disease
Identification of Epigenetic Biomarkers for Alzheimer's Disease in Blood Using Epigenome-wide Analysis
Source: ClinicalTrials.gov · Last updated 29 Apr 2025
Brief summary (registry, in English)
Alzheimer's disease (AD) is a neurodegenerative disorder with no know cure. The pathogenesis of late onset AD (LOAD) is complex and multifactorial in nature, with multiple susceptibility genes and environmental factors at interplay. The objective of this study is to improve our understanding of the risk factors of LOAD by conducting an epigenome wide study within patients of LOAD contrasted against their cognitively normal siblings.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 250 (actual)
- First submitted
- 23 Jul 2019
- Start date
- 1 Sept 2019
- Primary completion date
- 30 Nov 2024
- Lead sponsor
- Chinese University of Hong Kong
- Diseases
- Alzheimer disease
- NCT number
- NCT04081285
What you commit to
- Study type: Observational
- Participants enrolled: 250
- From 1 Sept 2019 to the primary completion date, 30 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Subjects who refuse blood taking procedure
- Do not have a reliable family/caregiver informant (personal contact at least once a month)
Who the study is looking for
- Sufficient Cantonese competency for cognitive test
- Written informed consent given
- Have at least one gender-matched cognitively normal sibling
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Chinese University of Hong Kong Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.